Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Standard

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency. / Santamaria, Manuel; Neth, Olaf; Douglass, Jo A; Krivan, Gergely; Kobbe, Robin; Bernatowska, Ewa; Grigoriadou, Sofia; Bethune, Claire; Chandra, Anita; Horneff, Gerd; Borte, Michael; Sonnenschein, Anja; Kralickova, Pavlina; Ramón, Silvia Sánchez; Langguth, Daman D; Gonzalez-Granado, Luis Ignacio; Alsina, Laia; Querolt, Montse; Griffin, Rhonda; Hames, Carrie; Mondou, Elsa; Price, Jeffrey; Sanz, Ana; Lin, Jiang.

In: J CLIN IMMUNOL, Vol. 42, No. 3, 04.2022, p. 512-513.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Santamaria, M, Neth, O, Douglass, JA, Krivan, G, Kobbe, R, Bernatowska, E, Grigoriadou, S, Bethune, C, Chandra, A, Horneff, G, Borte, M, Sonnenschein, A, Kralickova, P, Ramón, SS, Langguth, DD, Gonzalez-Granado, LI, Alsina, L, Querolt, M, Griffin, R, Hames, C, Mondou, E, Price, J, Sanz, A & Lin, J 2022, 'Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency', J CLIN IMMUNOL, vol. 42, no. 3, pp. 512-513. https://doi.org/10.1007/s10875-022-01219-3

APA

Santamaria, M., Neth, O., Douglass, J. A., Krivan, G., Kobbe, R., Bernatowska, E., Grigoriadou, S., Bethune, C., Chandra, A., Horneff, G., Borte, M., Sonnenschein, A., Kralickova, P., Ramón, S. S., Langguth, D. D., Gonzalez-Granado, L. I., Alsina, L., Querolt, M., Griffin, R., ... Lin, J. (2022). Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency. J CLIN IMMUNOL, 42(3), 512-513. https://doi.org/10.1007/s10875-022-01219-3

Vancouver

Bibtex

@article{8d5c0ac6dd744998b0ea8986683de3cb,
title = "Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency",
author = "Manuel Santamaria and Olaf Neth and Douglass, {Jo A} and Gergely Krivan and Robin Kobbe and Ewa Bernatowska and Sofia Grigoriadou and Claire Bethune and Anita Chandra and Gerd Horneff and Michael Borte and Anja Sonnenschein and Pavlina Kralickova and Ram{\'o}n, {Silvia S{\'a}nchez} and Langguth, {Daman D} and Gonzalez-Granado, {Luis Ignacio} and Laia Alsina and Montse Querolt and Rhonda Griffin and Carrie Hames and Elsa Mondou and Jeffrey Price and Ana Sanz and Jiang Lin",
year = "2022",
month = apr,
doi = "10.1007/s10875-022-01219-3",
language = "English",
volume = "42",
pages = "512--513",
journal = "J CLIN IMMUNOL",
issn = "0271-9142",
publisher = "Springer New York",
number = "3",

}

RIS

TY - JOUR

T1 - Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

AU - Santamaria, Manuel

AU - Neth, Olaf

AU - Douglass, Jo A

AU - Krivan, Gergely

AU - Kobbe, Robin

AU - Bernatowska, Ewa

AU - Grigoriadou, Sofia

AU - Bethune, Claire

AU - Chandra, Anita

AU - Horneff, Gerd

AU - Borte, Michael

AU - Sonnenschein, Anja

AU - Kralickova, Pavlina

AU - Ramón, Silvia Sánchez

AU - Langguth, Daman D

AU - Gonzalez-Granado, Luis Ignacio

AU - Alsina, Laia

AU - Querolt, Montse

AU - Griffin, Rhonda

AU - Hames, Carrie

AU - Mondou, Elsa

AU - Price, Jeffrey

AU - Sanz, Ana

AU - Lin, Jiang

PY - 2022/4

Y1 - 2022/4

U2 - 10.1007/s10875-022-01219-3

DO - 10.1007/s10875-022-01219-3

M3 - Other (editorial matter etc.)

C2 - 35174440

VL - 42

SP - 512

EP - 513

JO - J CLIN IMMUNOL

JF - J CLIN IMMUNOL

SN - 0271-9142

IS - 3

ER -